NextCell’s daughter company Cellaviva granted permission to handle amniotic tissue
NextCell Pharma AB ("NextCell" or the "Company") today announces that the Swedish Health and Social Care Inspectorate (IVO) has granted their Cellaviva tissue establishment permission to handle amniotic tissue. Cellaviva is the largest private stem cell bank in the Nordics. Since the launch of the cord blood bank in 2014, the company has increased the business model to include genetic tests and tissue handling services for biotech companies and hospitals.Cellaviva is expanding business-to-business activities by broadening their tissue establishment permission to include aminiotic tissues.